Cancer of the paranasal sinuses is rare, accounting for only 3% of head and neck malignancies. I In the past, extension of a malignancy of the sinuses to the skull base was considered a contraindication for curative surgical resection. The advent of the combined craniofacial surgical approach to the anterior skull base has, however, brought surgical resection of such malignancies into the realm of acceptable treatment.
al'0 described the resection of paranasal sinus neoplasms using a transcranial technique.
Despite the relative success of these surgical procedures in the management of tumors involving the anterior skull base, the selection of initial treatment of cancer involving the ethmoid sinus remains a reflection of the philosophy of the treating physician or individual institution. Traditionally, surgery has been reserved for cancer of the ethmoid sinus which approaches but does not invade the skull base. In many institutions, external irradiation has been the initial treatment of choice for ethmoid sinus cancer with intracranial extension. 11, 12 Based on our recent experience utilizing the transcranial approach in the surgical treatment of ethmoid sinus cancer involving the anterior skull base, we propose a reappraisal of the traditional indications for surgery based on a meticulous pretreatment radiologic evaluation and the histopathology of each neoplasm.
MATERIALS AND METHODS
Between January 1985 and August 1990, 11 SKULL BASE SURGERYNOLUME 2, NUMBER 4 OCTOBER 1992 resection of malignancies arising in the ethmoid sinuses and encroaching on or invading the anterior skull base. Of the options available for the management of these patients, the transcranial approach was utilized in order to provide an oncologically sound tumor resection with the lowest possible risk of developing a postoperative cerebrospinal fluid (CSF) fistula. Unilateral orbital involvement and intracranial extension into the frontal lobes did not exclude this approach, but bone invasion posterior to the suture line between the lesser sphenoid wing and the orbital plate of the frontal bone was considered a contraindication.
Of the 11 patients, seven were male and four were female. The various pathologic entities included three squamous cell carcinomas, three undifferentiated carcinomas, three adenocarcinomas, and two adenoid cystic carcinomas. All patients were classified as having T4 lesions using the American Joint Committee Staging System for paranasal sinus carcinomas. 13 Disease was limited to the ethmoid sinus without invasion of the dura or orbit in one patient. In eight patients cancer invaded the orbit and two patients had intracranial invasion through the dura (Table 1) . One patient (patient 10) also had metastatic disease in the neck.
Only 1 of the 11 patients had received cancer treatment prior to presentation to us. This patient (patient 10) had received 60 Gy external beam radiotherapy to the anterior skull base for attempted cure 10 years earlier.
The majority of these patients presented with nasal obstruction and discharge associated with localized pain. Epistaxis had occurred in six patients and four presented with visual complaints. The duration of symptoms prior to initial treatment ranged from 3 to '4 to support the dural repair when an orbital exenteration is necessary. All patients have been followed postoperatively by the authors in the routine manner for patients with head and neck cancer until the time of death or the date of this report. CT or MRI have been performed every 6 to 12 months during the postoperative follow-up period. Follow-up survival analysis was performed using the Kaplan-Meier product limit method, and comparison between the individual subgroups was done using the logrank test.
RESU LTS
Of the 11 patients undergoing transcranial resection of ethmoid sinus cancer, there were no deaths during the 30-day period following surgery. No neurologic deficits were noted following surgery and only one patient developed a CSF leak. This patient (patient 4) required an indwelling lumbar drain followed by a ventricular-peritoneal shunt to resolve the CSF leak. In two patients (patients 7 and 9), postoperative infection in the epidural space developed, necessitating the removal of an infected bone flap. Both patients rapidly recovered and are currently neurologically intact. The orbit proved at the time of surgery to be invaded by cancer in six patients, necessitating orbital exenteration and, thus, surgically created unilateral blindness. The orbit was not exenterated in two additional patients even though a pretreatment CT confirmed orbital invasion in both. In the first patient (patient 3), surgery followed an excellent response to chemotherapy and no orbital invasion was seen intraoperatively. In the second patient (patient 10) orbital exenteration was refused by the patient. In two additional patients (patients 1 and 3), unilateral blindness developed secondary to radiation therapy. Progressive loss of vision in the only seeing eye continues to this date in patient 1 (Table 1) .
Survival analysis data according to the pathologic diagnosis is shown in Figure 1 and according to sites of involvement is demonstrated in Figure 3 . Disease-free survival by pathologic diagnosis is illustrated by Figure 2 , and Figure 4 portrays disease-free survival according to sites of tumor invasion. In the entire series, local control as achieved in 7 of 11 patients.
DISCUSSION
The results in this series of 11 patients undergoing transcranial resection as primary treatment . unexpected spread of cancer into the middle cranial fossa necessitated resection of dura well posterior to the lesser wing of the sphenoid, compromising dural repair. Such a case points out the need for meticulous pretreatment radiologic evaluation of these patients.
The largest series of patients with paranasal sinus cancer treated with curative intent by radiation therapy is that reported by Parsons et al,11 a series of 48 patients, which provides an excellent source ofcomparison with our surgical series and that reported by Shah et a17 in terms of morbidity ( Table 2) . As can been seen in this table, mortality, neurologic deficits, and even the incidence of CSF leaks in these three series is comparable. As noted earlier, the main morbidity in the surgical patients appears to be secondary to infection of the epidural space with resultant bone flap loss, and this is not often seen in patients treated primarily with irradiation. Of note, however, are the orbital complications of radiation therapy. One third of the patients treated by Parsons et all' developed unilateral blindness and 8%, bilateral blindness. This compares with a 54% and 17% incidence of unilateral blindness in the surgical series reported herein and by Shah et al,7 reflecting the need to exenterate the orbit for direct cancer invasion. No patient in the series reported by Shah et a17 or in this series developed bilateral blindness secondary to surgery. In addition, two of our patients (18%) developed unilateral blindness secondary to adjunctive radiotherapy. The risk of eye injury following adjunctive postoperative irradiation has been addressed by Karim et al,15 who reported a 16% partial loss of vision and a 2% incidence of blindness in such circumstances. Thus, it would appear that morbidity following major extirpative surgery for ethmoid sinus cancer involving the ACF floor is, at worst, comparable to that of curative radiation therapy.
The major determinant of disease control and survival following surgery in this series of patients was tumor histologic classification. As shown in Figures 1 and 2 , good to excellent local control and survival were achieved for adenoid cystic carcinoma, adenocarcinoma, and squamous cell carcinoma, a finding similar to that reported by Ketcham and Van Buren6 and Shah et al. 7 Only one of our three patients with undifferentiated carcinoma, on the other hand, experienced disease-free survival beyond 14 months. The poor prognosis for undifferentiated carcinoma of the ethmoid sinus has been documented by others. [6] [7] [8] The impact of dural, orbital, and a combination of dural and orbital invasion on patient survival and disease control is depicted in Figures 3 and 4 . Although the combination of dural and orbital invasion appears to affect survival adversely (Fig. 3) and invasion of dura, orbit, or both has been associated with local recurrence (Fig. 4) , these findings were largely a result of such invasion in patients with undifferentiated carcinoma. Excluding these patients, good to excellent local control and survival were found in our series for relatively well-differentiated cancer of the ethmoid sinus despite invasion of the dura or orbit. Local control was achieved in the only patient with welldifferentiated cancer confined to the ethmoid sinus in one of two patients with dural invasion and in 4 of 5 patients with orbital invasion. All patients treated for well-differentiated cancer continue to survive at the time of this publication, 17 months to 7 years postoperatively, although two are living with recurrent disease, which presented at 14 and 18 months following surgery.
In comparison, Parsons et all' noted that 8 of 48 patients with cancer of the paranasal sinuses and nasal cavity treated with curative intent by radiotherapy had evidence of invasion of the skull base. Four of these eight had cancer of the paranasal sinus: two had adenocarcinoma, one had squamous cell carcinoma, and one had adenoid cystic carcinoma. Of these four patients, only one patient with adenocarcinoma was alive and free of disease 3.5 years following treatment."I Once again, these results would suggest an advantage of primary surgery over curative dose radiotherapy in the treatment of well-differentiated cancers of the ethmoid sinus involving the ACF floor.
The value of postoperative radiotherapy cannot be ascertained in our series, since all but two patients received this treatment (Table 1) . However, based on patterns of local recurrence in our patients, we believe that adjunctive radiotherapy plays a valuable role in local tumor control. SKULL BASE SURGERYNOLUME 2, NUMBER 4 OCTOBER 1992 Our experience with chemotherapy in the treatment of these patients has been minimal. In one patient with undifferentiated carcinoma (patient 3), preoperative chemotherapy (a combination of 5-fluorouracil and cisplatin) and radiation therapy proved remarkably effective (Table  1) . No viable neoplasm was found at the time of surgery, and the patient continues to be disease-free, 4½2 years following treatment. A recent report by LoRusso et al '6 has suggested a responsiveness of paranasal sinus carcinoma to cisplatin-containing combinations. Intra-arterial chemotherapy used in advanced tumors of the paranasal sinuses has been reported by Lee et al '7 with immediate satisfying tumor responses in 91% of patients. Given the generally poor prognosis of undifferentiated carcinoma of the paranasal sinuses found in this series and others,6-8 we would recommend both preoperative radiotherapy and chemotherapy in these cases before attempting surgical resection.
The number of patients treated for ethmoid sinus cancer in this series is too small for any meaningful statistical analysis. Our experience, however, is similar to that of others6-12 and points out the need for a multiinstitutional, prospective study to evaluate the surgical and nonsurgical treatment of these and other malignancies that encroach on or invade the floor of the ACE ETHMOID SINUS CANCER-CLOSE, MICKEY REVIEWER'S COMMENTS Drs. Close and Mickey have done an excellent job of reviewing their recent experience using transcranial resection of ethmoid sinus cancers that involve the anterior skull base. I do appreciate the opportunity to react to this article. The authors describe a dura repair with a watertight closure before the skull base is entered. I seriously doubt that that significantly contributes to decreasing the potential for infection. Our craniofacial team at The Ohio State University does not routinely close the dura prior to the combined intracranial-extracranial resection and has not experienced a high frequency of intracranial infections (Schuller et al, 1989) .
The authors also cite an advantage of the transcranial resection as being the absence of facial incisions. We have also been bothered by the sometimes unsightly appearance of patients with the routine facial incisions for approaching the extracranial component of this disease. That motivated us to describe a combined intra-extra cranial approach that uses only one small incision of about 2 to 3 cm in length at the root of the nose that involves the removal of the maxilla and reinsertion of the maxilla (Schuller et al, 1992 ). This approach provides a level of security for resecting these tumors, which are so intimately involved with critically important extracranial structures, such as the globe, yet not producing a disabling postoperative deformity.
I do take exception when the authors state that they have "routinely used a vascularized free flap" to support the dural repair. That has not been our personal experience. There is no question that vascularized free muscle flaps are an important adjunct in certain selected cases. I do not think that they are needed in all cases, as described in this article.
Finally, the authors discuss the role of radiotherapy and chemotherapy. I think that reports such as this are important for all of us involved with this type of work to gain an appreciation of the biologic behavior of the disease. We have experienced similar results in our series and certainly are looking to increase the locoregional control and distant metastatic rates with the use of adjuvant therapy. However, I do not think that there is enough experience nationally to yet propose a prospective multi-institutional trial. That certainly will become necessary in the future, but I think that we are still in the realm of phase I/II trials where feasibility needs to be further evaluated for particular treatment schema. Once again, I congratulate the authors on a fine report.
David E. Schuller, M.D.
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